5Kelsen D, Jhawer M, Ilson D, et al. Analysis of survival with modified docetaxel, cisplatin, fluoreuracil ( mDCF), and bevacizumab ( BEV ) in patients with metastatic gastroesophageal ( GE ) adeneearcinoma: Results of a phase II clinical trial[ J]. ASCO Meeting,2009 ;27:4512.
8WHO. 1994 World Health Statistics Annual. Geneve: WHO, 1995 ,B4-B347.
9Limburg P, Qiao Y, Mark S, et al. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer.Inst, 2001,93:226-233.
10Pisani P, Parkin DM, Ferlay J, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 1999,83: 18-29.
3Algire GH, Chalkley HW, Legallais FY, et al. Vasculae reactions of normal and malignant tissues in vivo. I. vascular reactions of mice to wounds and to normal and neoplastic transplants [ J ]. J National Cancer Institute, 1945,6 ( 1 ) :73 - 85.
4Folkman J. Tumor angiogenesis : therapeutic implications[ J ]. N En- gl J Med,1971,285 :1182 - 1186.
5Vifials F, Pouyssgur J. Transforming growth factor 131 (TGF - B1 ) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF - CL signaling[ J ]. Molecul Cellular Bio1,2001,21 (21) :7218 -7230.
6Norrby K. Mast cells and angiogenesis [ J ]. Apmis, 2002,110 ( 5 ) : 355 -371.
7Folkman J, Cole P, Zimmerman S. Tumor behavior in isolated per- fused organs:in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment [ J]. Ann Surg, 1966, 164(3) :491.
8Gimbrone MA, Leapman SB, Cotran RS, et al. Tumor dormancy in vivo by prevention of neovascularization[ J ]. J Exp Med, 1972,136 (2) :261 -276.
9Folkman J. Tumor angiogenesis [ J ]. Adv Cancer Res, 1974,19 : 331 -358.
10Folkman J. How is blood vessel growth regulated in normal and neo- plastic tissue - GHA Clowes memorial award lecture [ J ]. Cancer Res, 1986,46 (2) :467 - 473.
